Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Utomilumab by Pfizer for Follicular Lymphoma: Likelihood of Approval
Utomilumab is under clinical development by Pfizer and currently in Phase II for Follicular Lymphoma. According to GlobalData, Phase II...